Unit of Anesthesia, Intensive Care Unit and Pain Medicine, Faculty of Pharmacy and Medicine, Department of Medical and Surgical Sciences and Biotechnologies, SAPIENZA University of Rome, Italy.
Curr Pharm Des. 2012;18(37):6043-52. doi: 10.2174/138161212803582540.
Nausea and vomiting are common gastrointestinal symptoms following opioid administration, for either chronic or acute pain management. As a consequence, patients' dissatisfaction has a negative impact on treatment efficacy. A number of mechanisms have been identified, involving both central and peripheral sites. This article will review the pathophysiology of opioid-induced nausea and vomiting and the various pharmacological treatments currently available for its management. Preventive strategies and therapeutic approaches are evaluated in the perioperative setting and in chronic pain. Newer drugs include second generation serotonin receptor antagonists (palonosetron) and neurokinin-1 (NK-1) antagonists (aprepitant).
恶心和呕吐是阿片类药物治疗慢性或急性疼痛后常见的胃肠道症状。因此,患者的不满会对治疗效果产生负面影响。已经确定了一些涉及中枢和外周部位的机制。本文将综述阿片类药物引起的恶心和呕吐的病理生理学,以及目前可用于其治疗的各种药物治疗方法。在围手术期和慢性疼痛中评估了预防策略和治疗方法。新型药物包括第二代 5-羟色胺受体拮抗剂(帕洛诺司琼)和神经激肽-1(NK-1)拮抗剂(阿瑞匹坦)。